Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days

New feature: Automatically detect candlestick patterns on any chart

Predictive Oncology Inc.

Contributing Author

Recent Articles by Predictive Oncology Inc.

Dec-12	Predictive Oncology Becomes Axe Compute, Expanding Into High-Performance AI Infrastructure AGPU GlobeNewswire
Dec-02	Predictive Oncology Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement GlobeNewswire
Nov-14	Predictive Oncology Reports Third Quarter 2025 Financial Results and Provides Update on Digital Asset Strategy GlobeNewswire
Oct-14	Predictive Oncology Announces Additions to Board and Leadership Team to Support Digital Asset Treasury Strategy GlobeNewswire
Oct-08	Predictive Oncology Inc. Announces Closing of $343.5 Million in Private Placements to Initiate Digital Asset Treasury Strategy GlobeNewswire
Sep-29	Predictive Oncology Inc. Announces Private Placements of $344 Million to Initiate a Digital Asset Treasury Strategy Focused on Aethir (ATH) Tokens GlobeNewswire
Sep-25	Predictive Oncology Announces 1-for-15 Reverse Stock Split GlobeNewswire
Sep-04	Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients GlobeNewswire
Aug-14	Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire
Jul-15	Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities GlobeNewswire
Jul-08	Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing GlobeNewswire
Jun-12	Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp GlobeNewswire
May-27	Court Denies Renovaro Motion for an Expedited Trial in July GlobeNewswire
May-22	AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition GlobeNewswire
May-20	Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health" GlobeNewswire
May-15	Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire

Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)